Danaher Corp (DHR) - Biotechnology Revenue (I:DCDHRBR)
Level Chart
Basic Info
|
Danaher Corp (DHR) - Biotechnology Revenue is at a current level of 1.798B, down from 1.85B last quarter and up from 1.713B one year ago. This is a change of -2.81% from last quarter and 4.96% from one year ago. |
|
Danaher Corp Biotechnology Revenue refers to the income generated by the company's business activities related to the biotechnology sector. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 1.798B |
| Latest Period | Sep 2025 |
| Last Updated | Dec 18 2025, 15:07 EST |
| Next Release | Jan 30 2026, 08:30 EST (E) |
| Average Growth Rate | -3.00% |
| Value from Last Quarter | 1.85B |
| Change from Last Quarter | -2.81% |
| Value from 1 Year Ago | 1.713B |
| Change from 1 Year Ago | 4.96% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File | Upgrade |
Historical Data
| Date | Value |
|---|---|
| September 26, 2025 | 1.798B |
| June 27, 2025 | 1.85B |
| March 31, 2025 | 1.612B |
| March 28, 2025 | 1.612B |
| December 31, 2024 | 1.869B |
| September 30, 2024 | 1.653B |
| September 27, 2024 | 1.653B |
| June 28, 2024 | 1.713B |
| March 31, 2024 | 1.524B |
| March 29, 2024 | 1.524B |
| December 31, 2023 | 1.759B |
| September 30, 2023 | 1.664B |
| September 29, 2023 | 1.664B |
| June 30, 2023 | 1.885B |
| March 31, 2023 | 1.864B |
| Date | Value |
|---|---|
| December 31, 2022 | 2.223B |
| September 30, 2022 | 2.053B |
| July 01, 2022 | 2.266B |
| April 01, 2022 | 2.216B |
| December 31, 2021 | 2.242B |
| October 01, 2021 | 0.00 |
| July 02, 2021 | 0.00 |
| April 02, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| October 02, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| July 03, 2020 | 0.00 |
| April 03, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
News
Basic Info
|
Danaher Corp (DHR) - Biotechnology Revenue is at a current level of 1.798B, down from 1.85B last quarter and up from 1.713B one year ago. This is a change of -2.81% from last quarter and 4.96% from one year ago. |
|
Danaher Corp Biotechnology Revenue refers to the income generated by the company's business activities related to the biotechnology sector. |
| Report | Fiscal.ai |
| Category | Segments & KPIs |
| Region | United States |
| Source | Fiscal.ai |
|
Data provided via Fiscal.ai |
Stats
| Last Value | 1.798B |
| Latest Period | Sep 2025 |
| Last Updated | Dec 18 2025, 15:07 EST |
| Next Release | Jan 30 2026, 08:30 EST (E) |
| Average Growth Rate | -3.00% |
| Value from Last Quarter | 1.85B |
| Change from Last Quarter | -2.81% |
| Value from 1 Year Ago | 1.713B |
| Change from 1 Year Ago | 4.96% |
| Frequency | Quarterly |
| Unit | USD |
| Adjustment | N/A |
| Download Source File | Upgrade |
Related Securities
Related Indicators
| Danaher Corp (DHR) - Former Life Sciences Operating Income | 574.00M USD |
| Danaher Corp (DHR) - Former Life Sciences Revenue | 3.59B USD |
| Danaher Corp (DHR) - Life Sciences Operating Income | 222.00M USD |
| Danaher Corp (DHR) - Life Sciences Revenue | 1.792B USD |
| Danaher Corp (DHR) - Non-Recurring Revenue | 1.036B USD |
| Danaher Corp (DHR) - Recurring Revenue | 5.017B USD |